Parkside Financial Bank & Trust’s Cogent Biosciences COGT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.45K	Hold	115	–	–	﹤0.01%	1930
2026 Q1	$4.43K	Hold	115	–	–	﹤0.01%	1866
2025 Q4	$4.08K	Hold	115	–	–	﹤0.01%	1870
2025 Q3	$1.65K	Buy	115 +44	+62%	+$521	﹤0.01%	2092
2025 Q2	$510	Buy	71 +6	+9%	+$33	﹤0.01%	2540
2025 Q1	$389	Buy	+65	New	+$510	﹤0.01%	2554

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Parkside Financial Bank & Trust's COGT Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Cogent Biosciences (COGT) position steady in Q2 2026 at 115 shares worth $4.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1930.

Parkside Financial Bank & Trust first reported a position in COGT in Q1 2025 and has held it in 6 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

Parkside Financial Bank & Trust held 115 shares of Cogent Biosciences worth $4.45K as of Q2 2026.
Parkside Financial Bank & Trust left its Cogent Biosciences share count unchanged in Q2 2026.
Cogent Biosciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1930 holding.
Parkside Financial Bank & Trust first reported a position in Cogent Biosciences in Q1 2025 and has held it in 6 quarters since.
323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.